RNF135 inhibitors pertain to a class of chemical compounds that have been investigated for their potential to modulate the activity of RNF135 (Ring Finger Protein 135), an E3 ubiquitin ligase enzyme. E3 ubiquitin ligases play essential roles in the process of ubiquitination, where they facilitate the transfer of ubiquitin molecules to target proteins, regulating their stability and cellular functions. RNF135 is involved in mediating protein degradation and modification, impacting various cellular pathways and protein networks. The study of RNF135 inhibitors has arisen from the scientific interest in understanding the functional significance of E3 ubiquitin ligases in cellular regulation and protein homeostasis. By targeting RNF135, these inhibitors have the potential to interfere with its enzymatic activity, leading to alterations in ubiquitination patterns and the turnover of specific target proteins. Researchers aim to unravel the functional consequences of inhibiting RNF135 and the subsequent effects on cellular processes, including protein degradation, signal transduction, and gene expression.
Chemically, RNF135 inhibitors encompass a diverse range of compounds, each designed to interact with specific structural motifs or binding sites within the RNF135 enzyme. Researchers explore various chemical scaffolds and modifications to achieve selectivity and potency in inhibiting RNF135 while minimizing potential off-target effects. The exploration of RNF135 inhibitors is an evolving area of research within the field of molecular biology and cellular regulation. Through rigorous experimentation and characterization of these inhibitors, scientists aim to elucidate their mode of action and their effects on ubiquitination dynamics and cellular pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $280.00 | 1 | |
A small molecule inhibitor that targets NEDD8-activating enzyme (NAE), which is involved in the activation of multiple E3 ubiquitin ligases, including RNF135. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A proteasome inhibitor that can indirectly affect the activity of RNF135 and other E3 ligases by preventing protein degradation. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Another proteasome inhibitor that may indirectly modulate the activity of E3 ligases like RNF135. | ||||||
Gossypol | 303-45-7 | sc-200501 sc-200501A | 25 mg 100 mg | $114.00 $225.00 | 12 | |
A natural product found in cottonseeds that has been studied for its potential to inhibit certain E3 ligases. | ||||||
Piperlongumine | 20069-09-4 | sc-364128 | 10 mg | $107.00 | ||
A natural compound with reported effects on the activity of certain E3 ligases. | ||||||
NSC697923 | 343351-67-7 | sc-391107 sc-391107A | 1 mg 5 mg | $15.00 $51.00 | 3 | |
A compound that has been studied for its potential to inhibit the E3 ubiquitin ligase HUWE1, but its effects on RNF135 are not well-established. | ||||||
(–)-Nutlin-3 | 675576-98-4 | sc-222086 sc-222086A | 1 mg 5 mg | $120.00 $215.00 | 2 | |
A compound that inhibits the interaction between MDM2 and p53, which could indirectly affect the activity of some E3 ligases. | ||||||